ALEAF - Aleafia Health Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.6197
-0.0703 (-10.19%)
At close: 3:59PM EST
Stock chart is not supported by your current browser
Trade prices are not sourced from all markets
Previous Close0.6900
Open0.7919
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.6111 - 0.7919
52 Week Range0.5200 - 2.2300
Volume1,030,831
Avg. Volume318,661
Market Cap171.592M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Benzinga

    Aleafia Health Reports First Profitable Quarter, With Q3 Net Income Of $1.86M

    Aleafia Health Inc . (TSX: ALEF) (OTC: ALEAF ) reported Tuesday with third-quarter total revenue of $5.29 million, up 34% from $3.95 million in the previous quarter. The company posted an adjusted EBITDA ...

  • Cronos turns lower after kicking off cannabis earnings with revenue miss
    MarketWatch

    Cronos turns lower after kicking off cannabis earnings with revenue miss

    Cronos Group kicked off the September quarter earnings season for the cannabis sector on Tuesday with a report showing a profit driven by a one-time gain and lower-than-expected revenue.

  • GlobeNewswire

    Aleafia Health Reports First Profitable Third Quarter

    Ultra low-cost production at $0.08 cost per gram at outdoor facilityAverage net revenue per gram equivalent of $15.11 for medical cannabis salesMedical cannabis sales up 43%.

  • Aleafia Health Outdoor Harvest Yields 10,300 kg of Dried Flower at $0.08 Cost per Gram
    GlobeNewswire

    Aleafia Health Outdoor Harvest Yields 10,300 kg of Dried Flower at $0.08 Cost per Gram

    Cannabinoid content per gram only slightly lower than identical strains grown indoorsCritical quality control tests successfulApproximately 1,000 kg yield per acre in Zone.

  • GlobeNewswire

    Aleafia Health to Announce 2019 Third Quarter Financial Results

    TORONTO, Oct. 23, 2019 -- Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF) (“Aleafia Health” or the “Company”) will announce its 2019 Third Quarter Financial Results on November 12,.

  • Barrons.com

    The Marijuana Stock Aphria Reports Its Earnings Tuesday. Here’s What to Watch.

    (APHA) will be the first marijuana company to report quarterly earnings since last week’s cannabis stock selloff. Its fiscal first-quarter earnings announcement is scheduled for Tuesday, after the market closes. Aphria stock (ticker: APHA) is down about 17% so far this year through Friday’s close at $4.71, while the S&P 500 index has risen 19%.

  • Aleafia’s Announcement Should Concern Aphria Stock Investors
    InvestorPlace

    Aleafia’s Announcement Should Concern Aphria Stock Investors

    Aphria (NYSE:APHA) shareholders continued to be disappointed as the APHA stock price drops. Despite this disappointment, no one is talking abut one piece of potentially bearish news -- and that should concern investors.Source: Shutterstock Aleafia Health (OTCMKTS:ALEAF) is a vertically integrated cannabis health and wellness company with a large presence in Canada. It produces cannabis-infused oils and capsules and it operates 25 medical clinics and education centers in Canada.So what is this bearish news? In September of last year, Aphria and Emblem Cannabis, a wholly owned subsidiary of Aleafia, came to an agreement that Aphria was to supply up to 175,000 kilograms of cannabis to Emblem. Had all gone according to plan, the five-year agreement should have started in May 2019.InvestorPlace - Stock Market News, Stock Advice & Trading TipsOn Tuesday Aleafia said that it was terminating this agreement. This clearly was not an amicable breakup. It its statement, Aleafia attributed its decision to "Aphria's failure to meet its supply obligations under the supply agreement." A Contentious RelationshipWhen a company makes a statement like this without trying to put any spin on it, it is usually a sign of a contentious relationship. For example, Aleafia could have used more diplomatic language and said something along the lines of "after careful consideration both companies have mutually decided that it was in their best interest to end the agreement."Aleafia's statement clearly puts a negative light on APHA. Aleafia also assured shareholders that this termination of the agreement would not have any material effect on its operations.What should concern Aphria's shareholders, in my opinion, is its response to the announcement. It did not offer any explanation or try to fight back in any way. In response the company said "We are disappointed that Aleafia has chosen to terminate its Agreement with Aphria Inc. The Company had every intention of fulfilling its obligations under the Agreement."So … what happened? Why couldn't Aphria keep up its side of the agreement? Was it due to logistics or operational issues? Was it due to the fact that Aphria isn't growing enough to meet the demand? A Closer Look at Aphria StockThe ambiguity and lack of explanation in this statement would concern me if I was a shareholder. Aphria's most recent investor presentation stated that the company's annual production capacity of its combined facilities is 255,000 kilograms. If the agreement with Aleafia was for up to 175,000 kilograms over five years, that could be up to 35,000 kilograms a year -- which is more than 10% of the total capacity.Will Aphria have similar problems supplying other companies? It next reports earnings on Oct. 15. This will probably be a topic of discussion on the earnings call. If there isn't more clarity on why Aleafia terminated the agreement, it could be a very bearish signal for APHA.APHA stock is currently testing -- and possible breaking support -- around the $5 level. There was support at this level in August and early October.At the time of this writing Mark Putrino did not have any holdings in the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Super Boring Stocks to Buy With Super Safe Returns * 10 Winning Stocks to Buy and Stick With for the Long Haul * Don't Give Up on These 4 Cannabis Stocks The post Aleafia's Announcement Should Concern Aphria Stock Investors appeared first on InvestorPlace.

  • GlobeNewswire

    Aleafia Health Announces Termination of Supply Agreement With Aphria Inc.

    Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) announces that it has provided Aphria Inc. (TSX: APHA, NYSE: APHA) (“Aphria”) with a formal notice of the termination, effective October 7, 2019, of the wholesale cannabis supply agreement (the “Supply Agreement”) dated September 11, 2018 between Aphria and Emblem Corp. (“Emblem”), a wholly-owned subsidiary of the Company, providing for the provision by Aphria of up to 175,000 kg equivalents of cannabis products over an initial five-year term, commencing May 1, 2019.

  • GlobeNewswire

    Aleafia Health Completes Construction, Secures Full Occupancy at Paris Processing Facility Expansion

    Features initial 115,000 kg of dried flower equivalent annual extraction capacity, with ability for further expansion on-site2,775% increase over Company’s current annual.

  • GlobeNewswire

    Aleafia Health Appoints New Lead Independent Director

    TORONTO, Oct. 02, 2019 -- The Board of Directors of Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) has appointed Lea Ray as its new.

  • If You Had Bought Aleafia Health (TSE:ALEF) Stock A Year Ago, You'd Be Sitting On A 70% Loss, Today
    Simply Wall St.

    If You Had Bought Aleafia Health (TSE:ALEF) Stock A Year Ago, You'd Be Sitting On A 70% Loss, Today

    The art and science of stock market investing requires a tolerance for losing money on some of the shares you buy. But...

  • GlobeNewswire

    Aleafia Health Provides Guidance for Profitable Third Quarter 2019

    Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) is pleased to provide guidance anticipating the Company will achieve positive net income for the three month period ended September 30, 2019. “Through prudent capital allocation, coupled with strong cannabis revenue growth, we now expect to deliver the first profitable quarter in Aleafia Health’s history, a major milestone. This will mark our second consecutive quarter featuring both substantial expense reductions and increased revenues as we continue to drive towards sustainable, compliant growth that will deliver real benefits to our stakeholders,” said Aleafia Health CEO Geoffrey Benic.

  • GlobeNewswire

    Aleafia Health Expands Outdoor Cannabis Facility by Additional 60 Acres with Property Acquisition

    Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”)’s wholly owned subsidiary, Aleafia Farms Inc., has acquired the farmland directly adjacent to its Port Perry Outdoor Grow facility. The purchase will allow the Company to commence its Outdoor Grow Phase II expansion, adding an additional 60 acres of cannabis cultivation area, for a total of 86 acres.

  • Aleafia Health Posts Record High Sales in Q2
    Motley Fool

    Aleafia Health Posts Record High Sales in Q2

    The Canadian cannabis producer looks for even stronger growth in the future thanks to its increased production capacity and entrance into new markets.

  • GlobeNewswire

    Aleafia Health Reports Record Revenue in Q2 2019, 159% Q/Q Revenue Increase

    Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) is pleased to provide a corporate update and report its Second Quarter 2019 financial results for the period ended June 30, 2019. Aleafia Health has filed its consolidated financial statements and related management’s discussion and analysis, both of which are available on Aleafia Health’s profile at www.SEDAR.com.  All financial information in this press release is reported in Canadian dollars, unless otherwise indicated. “The foundation that our team has built over the last year is now beginning to prove its worth as we report marked improvements with record revenue generated, significant cost reductions and a growing base of active, registered medical cannabis patients,” said Aleafia Health CEO Geoffrey Benic.

  • Aleafia Health: A Small-Cap Pot Stock Worth Considering Long Term
    TipRanks

    Aleafia Health: A Small-Cap Pot Stock Worth Considering Long Term

    Aleafia Health (ALEAF) is a little cannabis company that has legitimate growth potential; something many of its smaller peers, in reality, actually don't.The major catalysts that could propel the company to the next level is its facilities that are close to being licensed by Health Canada, and its recent acquisition of Emblem Cannabis Corporation, which is giving it more options and results than it was capable of before the deal.While the company has a lot to do and prove before I would be a believer, it has positioned itself to give it a chance to become a potential growth company with a future.Latest earningsIn the first quarter the company generated $1.5 million in revenue, up over 1,700 percent from the $0.1 million generated in the same reporting period a year ago.The company had a net loss of $20.2 million in the quarter, with an adjusted net loss of $7 million after excluding one-time, non-cash payments of $13.2 million associated with the closing of the acquisition of Emblem.It had $36.8 million in cash on its balance sheet at the end of March 2019, and total assets were at $61 million, including cash.Licensing getting closer to full approvalLicensing approval for Port Perry Outdoor Grow and Niagara Greenhouse moving along nicely.The Port Perry Outdoor Grow includes 1.1 million square feet of space, or approximately 26 acres. That's the same area its Port Perry Indoor facility is located. Aleafia said it finished the build-out of the site and on May 3 submitted its evidence package to Health Canada showing it meets all requirements to receive its License Amendment. It is currently under review.At the Port Perry Outdoor Grow facility it has already been approved for Zone 2, and has 13,000 plants currently growing at that location.The company also stated it has received a status update back from Health Canada concerning its 160,000 square foot Niagara Greenhouse facility, saying it had passed a high-level review, and so far there were no concerns communicated by Health Canada concerning the facility.It appears it won't be long before Aleafia receives both licenses, barring some unforeseen issue that needs to be fixed. Either way, I would be surprised if Aleafia doesn't get approved for both licenses soon.What Else Emblem Cannabis brings to the tableThe acquisition of Emblem Cannabis Corporation is a real potential game changer for Aleafia in a number of ways. First, it brings immediate revenue growth to the table, and has already entered into the biggest deal Aleafia has ever made.It reported that Emblem completed an adult-use cannabis order which is expected to generate sales exceeding $1 million, which has already been sent to a Canadian provincial government for online and physical retail distribution.Aleafia Health CEO Geoffrey Benic said closing the acquisition of Emblem will accelerate its "global mission of growing, processing and selling high-margin value-added cannabis products by 12 to 18 months.”Leveraging its growth facilities across Emblem's larger footprint should also boost growth going forward.On the global level, Emblem adds exposure to the important German market via its joint venture with German pharmaceutical wholesaler and logistics company Acnos Pharma GmbH.Aleafia now owns 60 percent of the joint venture, which includes access to about 20,000 pharmacies and 110 distribution centers.Outside of Emblem, Aleafia also has a 10 percent stake in Australian Licensed Producer CannaPacific Pty. Limited.The company already has received an Import Permit from the Australian Office of Drug Control, and has applied to Health Canada for an export permit.Emblem also has a top Canadian medical cannabis clinic that has seen 60,000 patients.ConclusionIf Aleafia successfully obtains its licenses and permits, and executes well in its production facilities once they're operational, it has positioned itself to go through a period of significant growth.The acquisition of Emblem has really upped the game for Aleafia, and if it manages to leverage the strengths of Emblem efficiently, it should surprise a lot of investors that don't pay much if any attention to the small cannabis company.There are no real guarantees with Aleafia Health, but among companies of its size or a little larger, it appears to have one of the stronger chances at achieving success. It's definitely worth watching closely.See Gary Bourgeault's stock picks on TipRanks

  • GlobeNewswire

    Aleafia Health to Announce 2019 Second Quarter Financial Results

    TORONTO, Aug. 07, 2019 -- Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) will announce its 2019 Second Quarter Financial Results on.

  • Aleafia Health Completes Largest Cannabis Order to Date, Provides Facility Update
    GlobeNewswire

    Aleafia Health Completes Largest Cannabis Order to Date, Provides Facility Update

    Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) is announcing that its wholly owned subsidiary, Emblem Cannabis Corporation, has completed the largest adult-use cannabis order (the “Order”) in the Company’s history. The value of the Order is expected to generate proceeds from the sale of cannabis exceeding $1.0 million, and has been shipped to a Canadian provincial government for distribution to online and retail consumers. The single Order features all of the Company’s product formats and 17 individual product SKUs.

  • 2 Penny Stock Marijuana Plays That Could Make You Rich
    Motley Fool

    2 Penny Stock Marijuana Plays That Could Make You Rich

    Aleafia Health and MedMen Enterprises are two penny pot stocks worth keeping tabs on.

  • Aleafia Health Secures Health Canada Licence Amendment for Entire 1.1M sq. ft. Port Perry Outdoor Cultivation Facility
    GlobeNewswire

    Aleafia Health Secures Health Canada Licence Amendment for Entire 1.1M sq. ft. Port Perry Outdoor Cultivation Facility

    Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) is pleased to announce that on July 12, 2019, Aleafia Health’s wholly-owned subsidiary, Aleafia Farms Inc., secured a License Amendment (the “Licence”) under Health Canada’s Cannabis Regulations authorizing cannabis cultivation for the entirety of the Company’s Port Perry Outdoor Grow facility. The Licence immediately increases the Company’s licensed and operational outdoor cultivation area from 292,000 sq. ft. to over 1.1 million sq. ft. As previously announced on June 10, 2019, Aleafia Farms received approval for cultivation in Zone 1 of the Outdoor Grow facility, and days later completed the planting of Canada’s first legal, large-scale outdoor crop.

  • GlobeNewswire

    Aleafia Health Added to NYSE-Listed The Cannabis ETF

    TORONTO, July 11, 2019 -- Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) has been added to The Cannabis ETF (NYSE: THCX) (“THCX”),.

  • 3 Marijuana Penny Stocks That Are Actually Major Players
    Motley Fool

    3 Marijuana Penny Stocks That Are Actually Major Players

    You could probably buy a share of each of these cannabis penny stocks with the loose change in your couch cushions.

  • GlobeNewswire

    Aleafia Health Secures Health Canada Permits to Export Cannabis Products to Australia

    Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) has received multiple Export Permits (the “Permits”) from Health Canada, which allow the Company to begin its first international cannabis product shipment. The Company expects to ship its branded medical cannabis oils in the next month, which will be distributed by Australian Licensed Producer CannaPacific Pty. Limited (“CannaPacific”).

  • 3 Marijuana Stocks That Are Book-Value Bargains
    Motley Fool

    3 Marijuana Stocks That Are Book-Value Bargains

    Two out of three of these pot stocks trade below their book value, but that may not make them worth buying.